Anlon Healthcare Preferential Issue

Financial Results

Anlon Healthcare Q2 FY27 Results: Net Profit ₹17.2 Cr, Up 84.9% YoY

Anlon Healthcare Ltd reported revenue from operations of ₹105.6 Cr (+102.3% YoY) and net profit of ₹17.2 Cr (+84.9% YoY) for Q2 FY27.

Key figure

Net profit ₹17.2 Cr · +84.9% YoY

Board Meeting Date

Anlon Healthcare Board Meeting Date

Anlon Healthcare will hold a board meeting on 29 October 2026 to consider unaudited standalone and consolidated half-yearly results. The trading window is closed from 1 October to 31 October 2026.

Other Announcement

Anlon Healthcare Other Announcement

Anlon Healthcare Limited filed the mandatory Regulation 74(5) certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Anlon Healthcare Fund Raise of ₹250 Cr

Anlon Healthcare approved a preferential issue of convertible warrants for up to Rs. 250 Crore to raise funds for the company.

Value

₹250.0 Cr

Board Meeting Date

Anlon Healthcare Board Meeting Date

Anlon Healthcare Ltd scheduled a board meeting for October 13, 2026, to deliberate on business expansion plans and potential fund-raising.

Merger & Restructuring

Anlon Healthcare Merger & Restructuring

Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.

Preferential IssueSealmatic India Ltd 543782

Sealmatic India Preferential Issue

Sealmatic India's EGM on 23 November 2026 seeks approval for a preferential issue of 3,61,620 shares at Rs 415 each. The issue aggregates Rs 15.01 Crore.

Value

₹15.01 Cr

Preferential IssueD P Abhushan Ltd DPABHUSHAN

D P Abhushan Preferential Issue

D.P. Abhushan's EoGM put two preferential issues to shareholders: equity shares and warrants at ₹1,430 each. Proposed proceeds total about ₹558.01 crore, mainly for retail expansion.

Value

₹558.0 Cr

Preferential IssueDhariwalcorp Ltd DHARIWAL

Dhariwalcorp Preferential Issue

Dhariwalcorp's EGM on October 29, 2026 considered a preferential issue of 33,00,000 shares to the promoter and 1,70,01,000 warrants. Voting results will be reported separately.

Preferential IssueOrchasp Ltd ORCHASP

Orchasp Preferential Issue

Orchasp revised the allottee-category detail in its AGM statement for a preferential issue, resubmitting for in-principle approval. The 1.5-crore-share issue is valued at Rs 7.11 Crore.

Value

₹7.11 Cr

Preferential IssueOne Global Service Provider Ltd ONEGLOBAL

One Global Service Provider Preferential Issue

One Global Service Provider allotted 7,06,068 preferential equity shares to two allottees, for consideration other than cash. Issue value is about Rs.39.54 Crore at the stated prices.

Value

₹39.54 Cr

Preferential IssueCCME Global Ltd SSK

CCME Global Preferential Issue

CCME Global's Preferential Issue Committee allotted about 15.08 crore equity shares worth Rs 150.84 crore, including shares for cash and for acquiring stakes in CCME UAE and Interlink. Both entities become associate and subsidiary respectively from October 28, 2026.

Value

₹150.8 Cr